The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Gene Editing Global Market Report 2024, the gene editing market is expected to show significant growth in the forecast period.

Introduction: The Explosive Growth of the Gene Editing Market

• Market size surged from $7.45 billion in 2023 to $8.76 billion in 2024.
• Compound Annual Growth Rate (CAGR) of 17.7% attributed to various factors.

Anticipated Expansion: Projections for the Future

• Estimated growth to $17.19 billion in 2028 at a CAGR of 18.4%.
• Forecast drivers: therapeutic applications expansion, precision enhancements, gene therapy commercialization.

Trends Shaping the Future

• Multiplex editing techniques.
• Base editing innovations.
• Gene drives and population modification.
• Non-viral delivery systems.
• Disease modeling and drug discovery.

View More On The Gene Editing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Role Of Gene Editing In Battling Communicable Diseases

• Crucial role in detecting and treating communicable diseases like HIV.
• Gene therapy addresses infectious diseases by impeding replication of the infectious agent.
• UNAIDS reports global HIV population increased to 39 million in 2022, highlighting the need for gene editing advancements.

Advancement In Gene Editing

• Introduction of innovative technologies by major companies in the gene editing market.
• Technique based on cell-penetrating peptides promises advantages in cell therapies for cancer and other diseases.
• Penn Medicine’s discovery of using protein fragments for high-efficiency CRISPR-Cas gene editing.

PerkinElmer Expands Portfolio And Gene Editing Capabilities With Sirion Biotech Acquisition

• PerkinElmer acquires SIRION Biotech to expand gene therapy and viral vector technologies.
• Acquisition strengthens PerkinElmer’s position in gene delivery technologies for better gene therapy development.

Market Segmentation

• By Technology: CRISPR, TALEN, ZFN.
• By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering.
• By End Users: Biotechnology, Pharmaceutical, Contract Research Organization.

Regional Analysis: North America Leading the Charge

• North America emerged as the largest region in the gene editing market in 2023.

Conclusion: Pioneering Progress in Genetic Innovation

• Gene editing stands as a pivotal frontier in medical innovation, offering solutions to combat communicable diseases and drive therapeutic advancements.
• With rapid growth and technological breakthroughs, the gene editing market is poised to revolutionize healthcare and agriculture, paving the way for a healthier and more sustainable future.

Request A Sample Of The Global Gene Editing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=2486&type=smp